Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived stem cells with calcium phosphate for maxillary sinus floor augmentation
NL-OMON24484Not yet recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of JOINTSTEM in Jawbone loss (ABL) and Alveolar bone atrophy (ABL) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Occurrence of any AE or SAE related to the product and/or procedure. Planned start Jan 2010; status: not yet recruiting.
02
Drugs
JOINTSTEM
03
Conditions
Jawbone loss (ABL)Alveolar bone atrophy (ABL)
Beyond the preview
Go deeper on NL-OMON24484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24484.